Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-22-001233
Filing Date
2022-02-11
Accepted
2022-02-11 18:44:12
Documents
1
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 form5-02112022_030254.html 5  
1 form5-02112022_030254.xml 5 16844
  Complete submission text file 0001415889-22-001233.txt   18143
Mailing Address 111 WEST LEMON AVE MONROVIA CA 91016
Business Address 111 WEST LEMON AVE MONROVIA CA 91016 626-305-5900
Xencor Inc (Issuer) CIK: 0001326732 (see all company filings)

EIN.: 201622502 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O XENCOR, INC. 111 WEST LEMON AVENUE MONROVIA CA 91016
Business Address
Kuch John J (Reporting) CIK: 0001591306 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-36182 | Film No.: 22623571